房颤女性缺血性卒中风险的时间趋势与临床意义
芬兰FinACAF研究纳入2007–2018年229 565例新发房颤患者(女性50.0%,平均72.7岁),比较女性与男性缺血性卒中发生率。
要点
- 女性房颤患者缺血性卒中粗发生率高于男性,但校正后关联随时间减弱。
- 2007–08年女性性别独立关联卒中率增高20%–30%,研究末期不再显著。
- 女性性别与卒中率的关联减弱主要由高卒中风险患者驱动。
核心结论
- 女性性别与缺血性卒中率的关联在2007–2018年间减弱并变得不显著。
- 女性性别或可不再作为估算房颤患者预期卒中率和口服抗凝治疗需求的独立因素。
研究设计与样本
- 芬兰FinACAF注册联动研究纳入2007–2018年芬兰所有新发房颤患者229 565例(女性50.0%,平均年龄72.7岁)。
- 计算缺血性卒中发生率和率比,并分析口服抗凝治疗时间与未治疗时间。
主要发现
- 2007–08年校正分析中女性性别独立关联缺血性卒中率增高20%–30%,研究末期该关联减弱且无统计学显著性。
- 分析口服抗凝治疗与未治疗时间,或仅考虑未治疗时间时,观察到相似趋势。
- 卒中率下降由高卒中风险患者驱动,低或中等卒中风险患者中女性性别与更高卒中率无关。
临床怎么用
- 在估算房颤患者预期卒中率和口服抗凝治疗需求时,可考虑不将女性性别作为独立风险因素。
- 需结合患者个体卒中风险综合评估抗凝决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Female sex has been linked with higher risk of ischaemic stroke (IS) in atrial fibrillation (AF), but no prior study has examined temporal trends in the IS risk associated with female sex. METHODS: The registry-linkage Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) study included all patients with AF in Finland from 2007 to 2018. Ischaemic stroke rates and rate ratios were computed. RESULTS: Overall, 229 565 patients with new-onset AF were identified (50.0% women; mean age 72.7 years). The crude IS incidence was higher in women than in men across the entire study period (21.1 vs. 14.9 events per 1000 patient-years, P < .001), and the incidence decreased both in men and women. In 2007-08, female sex was independently associated with a 20%-30% higher IS rate in the adjusted analyses, but this association attenuated and became statistically non-significant by the end of the observation period. Similar trends were observed when time with and without oral anticoagulant (OAC) treatment was analysed, as well as when only time without OAC use was considered. The decrease in IS rate was driven by patients with high IS risk, whereas in patients with low or moderate IS risk, female sex was not associated with a higher IS rate. CONCLUSIONS: The association between female sex and IS rate has decreased and become non-significant over the course of the study period from 2007 to 2018, suggesting that female sex could be omitted as a factor when estimating expected IS rates and the need for OAC therapy in patients with AF.
引用
- Teppo, Airaksinen, Jaakkola, et al. Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications. Eur Heart J. 2024. PMID: 38606837. doi:10.1093/eurheartj/ehae198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。